<

 
Data updated 2025-05-09 00:05:01
Translation DK > English
Need help for the searches?
[DISPLAY PATENT]
 
Choose application no.
 
Application no. and date18733442.0 (espacenet)  (Federated)  (European Patent Register), 20180531
Patent/reg. no. and dateDK/EP 3630061, 20240403
Publication date20200408
Priority no. and dateUS 201762514474 P, 20170602
EP pub. no. and date EP 3630061 20200408
Effective date
Applicant/ownerXeris Pharmaceuticals, Inc., 1375 West Fulton Street, Suite 1300
Chicago, IL 60607, US
Applicant ref. no.166586
InventorPRESTRELSKI, Steven J., c/o Xeris Pharmaceuticals, Inc.
180 N. LaSalle Street Suite 1600
Chicago
Illinois 60601, US,
SANDOVAL, Michael A., c/o Xeris Pharmaceuticals, Inc.
180 N. LaSalle Street Suite 1600
Chicago
Illinois 60601, US,
SLOAT, Brian R., c/o Xeris Pharmaceuticals, Inc.
180 N. LaSalle Street Suite 1600
Chicago
Illinois 60601, US
RepresentativeAWA Denmark A/S, Strandgade 56, 1401 København K, DK
Opponent
IPC ClassA61K 31/5513 (2006.01) , A61K 47/14 (2017.01) , A61K 47/16 (2006.01) , A61K 47/20 (2006.01) , A61K 47/22 (2006.01) , A61K 9/00 (2006.01) , A61K 9/08 (2006.01) , A61P 25/08 (2006.01) , A61P 25/14 (2006.01) , A61P 25/22 (2006.01) 
TitleUDFÆLDNINGSRESISTENTE, SMÅMOLEKYLÆRE LÆGEMIDDELFORMULERINGER
Int. application no.US2018035473
Int. publication no.WO2018222922
Related patent (certificate)
StatusDK/EP patent
Pædiatrisk forlængelse-
Udløbsdato for pædiatrisk forlængelse-

 
Home | Danish Patent and Trademark Office, Helgeshøj Allé 81, 2630 Tåstrup, Denmark Tel.: +45 4350 8000, email | Contact